Related Experiment Video

Updated: Sep 26, 2026

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

Signaling protein networks as targets of new antineoplastic drugs

S Alberti1, S Parodi

  • 1Laboratory of Experimental Oncology, Department of Cell Biology and Oncology, Mario Negri Institute-Consorzio Mario Negri Sud, Santa Maria Imbaro (CH), Italy. alberti@negrisud.it

The International Journal of Biological Markers
|April 18, 2003
PubMed

Insights

Understanding cancer molecular networks offers new therapeutic targets and drug discovery strategies. Advanced "-omic" approaches and novel medicinal chemistry techniques promise more selective and effective cancer treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Cancer pathophysiology is complex, involving intricate molecular regulatory networks.
  • Identifying key molecular targets is crucial for developing novel therapeutic strategies.
  • Existing targeted therapies demonstrate the potential of this approach.

Purpose of the Study:

  • To explore the potential of molecular regulatory networks in cancer for improved understanding and treatment.
  • To identify and validate novel molecular targets for cancer therapy.
  • To investigate advanced drug discovery methods for enhanced selectivity and effectiveness.

Main Methods:

  • In-depth analysis of cancer molecular regulatory networks.
  • Utilizing omics approaches to understand signaling networks and drug mechanisms.
  • High-throughput screening of chemical libraries and microbial extracts.
  • Employing novel medicinal chemistry strategies, such as rosary-bead chains, for protein-protein interaction modulation.

Main Results:

  • Established proof-of-principle for targeted cancer therapy with existing drugs.
  • Identified specific molecular targets like c-Myc, Cyclin D1, Bcl-XL, kinases, and nuclear receptors.
  • Demonstrated the potential of omics and advanced medicinal chemistry for discovering novel drug candidates.

Conclusions:

  • Detailed molecular tumor taxonomy can be designed through network analysis.
  • Novel therapeutic approaches can be developed by targeting key molecular pathways.
  • Advanced screening and medicinal chemistry strategies offer superior selectivity and effectiveness in drug discovery.

Related Concept Videos

Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...